Sulphasalazine therapy in chronic uveitis of children with chronic arthritis.
Asian Pac J Allergy Immunol
;
1997 Jun; 15(2): 71-5
Article
in English
| IMSEAR
| ID: sea-37219
ABSTRACT
Four children with chronic arthritis (3 juvenile rheumatoid arthritis and 1 juvenile ankylosing spondylitis) and poorly controlled chronic uveitis, were given sulphasalazine (SASP) therapy for a mean period of 3.3 years. Three patients showed an excellent response, as evidenced by a reduction of inflammatory cells in the anterior chamber of the eyes and improvement of visual acuity. The response occurred after a mean of 7.7 weeks. These data suggested SASP therapy may have a role in the treatment of chronic anterior uveitis in children with chronic arthritis.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Arthritis, Juvenile
/
Sulfasalazine
/
Spondylitis, Ankylosing
/
Female
/
Humans
/
Male
/
Iridocyclitis
/
Child
/
Chronic Disease
/
Retrospective Studies
Type of study:
Observational study
Language:
English
Journal:
Asian Pac J Allergy Immunol
Year:
1997
Type:
Article
Similar
MEDLINE
...
LILACS
LIS